Oxaliplatin and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxaliplatin (oxaliplatin) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include septic shock among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Oxaliplatin and Cipro. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Oxaliplatin?

Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

On Jul, 18, 2026

54 people who take Oxaliplatin and Cipro together, and have interactions are studied.

Oxaliplatin and Cipro drug interactions.

What are the common drug interactions of Oxaliplatin and Cipro, by gender? *:

female:

Septic shock (shock due to blood infection)
Somnolence (a state of near-sleep, a strong desire for sleep)
Corneal perforation (small hole in a cornea)
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Ill-defined disorder
Oropharyngeal pain
Pneumonia
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Abdominal discomfort
Abdominal tenderness

male:

Dehydration (dryness resulting from the removal of water)
Pyrexia (fever)
Anaemia (lack of blood)
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)
Hepatic failure (liver failure)
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Malignant neoplasm progression (cancer tumour came back)
Septic shock (shock due to blood infection)
Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Oxaliplatin and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Alanine aminotransferase increased
Hepatocellular injury (liver injury)

40-49:

Large intestine perforation (hole in large intestine)

50-59:

Anaemia (lack of blood)
Benign hepatic neoplasm (benign (non-cancerous) tumours of the liver)
Blood pressure decreased
Bone pain
Cholecystitis (infection of gallbladder)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Clostridium test positive
Constipation
Discomfort
Disease progression

60+:

Diarrhoea
Pyrexia (fever)
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Mucosal inflammation (infection of mucous membrane)
Oesophagitis (inflammation of oesophagus)
Pain in extremity
Urinary retention (the inability to completely or partially empty the bladder)
Abnormal faeces (abnormal stool)
Benign prostatic hyperplasia (benign enlargement of the prostate)
Decreased appetite

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 12 people, 22.22%
High Blood Pressure: 9 people, 16.67%
Constipation: 8 people, 14.81%
Pain: 8 people, 14.81%
Infection: 7 people, 12.96%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 12.96%
Rectal Cancer (cancer of rectum): 6 people, 11.11%
Diarrhea: 6 people, 11.11%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 9.26%
Insomnia (sleeplessness): 4 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Oxaliplatin and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously